We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Measuring Reading Rehabilitation Outcomes

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00125632
First Posted: August 1, 2005
Last Update Posted: February 5, 2009
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
VA Office of Research and Development
  Purpose
The purpose of this study is to measure the effectiveness of a newly-designed oculomotor training program for patients with age-related macular degeneration.

Condition Intervention
Age Related Maculopathy Retinal Degeneration Procedure: Eccentric Viewing Training for Reading

Study Type: Interventional
Study Design: Allocation: Non-Randomized
Intervention Model: Crossover Assignment
Masking: Double
Official Title: Measuring Reading Rehabilitation Outcomes

Resource links provided by NLM:


Further study details as provided by VA Office of Research and Development:

Primary Outcome Measures:
  • Participants will be given the following assessment tests at 4 different times during the assessment (at baseline, after 6 weeks, after 12 weeks, and after 18 weeks): eye tracking measures, daily performance measures and reading measures.

Estimated Enrollment: 90
Study Start Date: August 2005
Study Completion Date: May 2008
  Show Detailed Description

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Patients with a diagnosis of AMD
  • An established preferred retinal locus
  • Visual acuity of less than or equal to 20/70 and greater than or equal to 20/400 (in the better eye)

Exclusion Criteria:

  • Those with other major ophthalmologic and neurologic disease; choroidal neovascularization ("wet" AMD); moderate to severe media opacities; and cognitive impairment
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00125632


Locations
United States, Illinois
Jesse Brown VA Medical Center
Chicago, Illinois, United States, 60612
Sponsors and Collaborators
VA Office of Research and Development
Investigators
Principal Investigator: Janet P Szlyk, Ph.D. Research & Development Service 151, Jesse Brown VA Medical Center
  More Information

Additional Information:
Publications:
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
ClinicalTrials.gov Identifier: NCT00125632     History of Changes
Other Study ID Numbers: O3877R
First Submitted: July 28, 2005
First Posted: August 1, 2005
Last Update Posted: February 5, 2009
Last Verified: December 2006

Keywords provided by VA Office of Research and Development:
Reading
Rehabilitation
Treatment Outcomes
Low vision

Additional relevant MeSH terms:
Retinal Degeneration
Retinal Diseases
Eye Diseases